Chryssanthou Erja, Cuenca-Estrella Manuel
Department of Clinical Microbiology, L202 Karolinska Hospital, S-171 76 Stockholm, Sweden.
J Clin Microbiol. 2002 Oct;40(10):3841-4. doi: 10.1128/JCM.40.10.3841-3844.2002.
The proposed standard of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antibiotic Susceptibility Testing (AFST-EUCAST) and the E-test procedures were compared with the NCCLS reference broth microdilution method for voriconazole and caspofungin susceptibility testing of 102 clinical Candida species and Saccharomyces cerevisiae isolates. The voriconazole MIC at which 50% of strains were inhibited (MIC(50)) was < or =0.125 mg/liter for all yeast species except for Candida glabrata and Candida krusei, which yielded MIC(50) values of 0.25 to 1 mg/liter depending on the method. Caspofungin exhibited in vitro activity (MIC(50) of < or =0.125 to 2 mg/liter) against all yeast species except for Candida guilliermondii. The agreements between MICs within +/-2 dilutions obtained by the NCCLS method and the EUCAST standard were 97% for voriconazole and 96% for caspofungin. Intraclass correlation coefficients were statistically significant (P < 0.05). The agreements between voriconazole MICs provided by the E-test and the NCCLS and between the E-test and the AFST-EUCAST method were 100 and 90%, respectively. Because of lower caspofungin MICs provided by the E-test, the agreement was slightly poorer with the NCCLS method (89%) than with the AFST-EUCAST procedure (94%). Both the EUCAST and the E-test procedures can be reliable techniques for susceptibility testing of yeasts to voriconazole and caspofungin.
将欧洲抗生素敏感性试验委员会抗真菌药敏试验小组委员会(AFST-EUCAST)提议的标准和E-test方法,与美国国家临床实验室标准委员会(NCCLS)参考肉汤微量稀释法,针对102株临床分离的念珠菌属和酿酒酵母进行伏立康唑和卡泊芬净药敏试验进行了比较。除光滑念珠菌和克柔念珠菌外,所有酵母菌种的伏立康唑最低抑菌浓度(MIC),即50%菌株被抑制时的浓度(MIC50)≤0.125mg/L,而光滑念珠菌和克柔念珠菌的MIC50值根据方法不同为0.25至1mg/L。卡泊芬净对除季也蒙念珠菌外的所有酵母菌种均表现出体外活性(MIC50≤0.125至2mg/L)。NCCLS方法与EUCAST标准在±2倍稀释范围内获得的MIC之间的一致性,伏立康唑为97%,卡泊芬净为96%。组内相关系数具有统计学意义(P<0.05)。E-test法与NCCLS法以及E-test法与AFST-EUCAST法提供的伏立康唑MIC之间的一致性分别为100%和90%。由于E-test法提供的卡泊芬净MIC较低,与NCCLS方法的一致性(89%)略低于与AFST-EUCAST方法的一致性(94%)。EUCAST标准和E-test方法均可以作为酵母对伏立康唑和卡泊芬净药敏试验的可靠技术。